Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy.
Brinkhuis F, Julian E, van den Ham H, Gianfrate F, Strammiello V, Berntgen M, Pavlovic M, Mol P, Wasem J, Van Dyck W, Cardone A, Dierks C, Schiel A, Bernardini R, Solà-Morales O, Ruof J, Goettsch W. Brinkhuis F, et al. Among authors: goettsch w. Health Res Policy Syst. 2024 Jul 2;22(1):74. doi: 10.1186/s12961-024-01154-2. Health Res Policy Syst. 2024. PMID: 38956568 Free PMC article.
Standardized reporting for rapid relative effectiveness assessments of pharmaceuticals.
Kleijnen S, Pasternack I, Van de Casteele M, Rossi B, Cangini A, Di Bidino R, Jelenc M, Abrishami P, Autti-Rämö I, Seyfried H, Wildbacher I, Goettsch WG. Kleijnen S, et al. Int J Technol Assess Health Care. 2014 Nov;30(5):488-96. doi: 10.1017/S0266462314000609. Int J Technol Assess Health Care. 2014. PMID: 25747557
Illustrating the Financial Consequences of Outcome-Based Payment Models From a Payers Perspective: The Case of Autologous Gene Therapy Atidarsagene Autotemcel (Libmeldy®).
Callenbach MHE, Schoenmakers D, Vreman RA, Vijgen S, Timmers L, Hollak CEM, Mantel-Teeuwisse AK, Goettsch WG. Callenbach MHE, et al. Among authors: goettsch wg. Value Health. 2024 Aug;27(8):1046-1057. doi: 10.1016/j.jval.2024.05.010. Epub 2024 May 23. Value Health. 2024. PMID: 38795960 Free article.
Roadmap to Innovation of HTA Methods (IHTAM): insights from three case studies of quantitative methods.
Jiu L, Wang J, Versteeg JW, Zhang Y, Liu L, Somolinos-Simón FJ, Tapia-Galisteo J, García-Sáez G, Hogervorst MA, Li X, Mantel-Teeuwisse AK, Goettsch WG. Jiu L, et al. Among authors: goettsch wg. Int J Technol Assess Health Care. 2024 Nov 5;40(1):e49. doi: 10.1017/S0266462324000564. Int J Technol Assess Health Care. 2024. PMID: 39498479 Free PMC article.
Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data: A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice.
Hogervorst MA, Soman KV, Gardarsdottir H, Goettsch WG, Bloem LT. Hogervorst MA, et al. Among authors: goettsch wg. Value Health. 2025 Jan;28(1):161-174. doi: 10.1016/j.jval.2024.08.002. Epub 2024 Sep 4. Value Health. 2025. PMID: 39241824 Free article. Review.
Framework for Multistakeholder Patient Registries in the Field of Rare Diseases: Focus on Neurogenetic Diseases.
Schoenmakers DH, van den Berg S, Timmers L, Adang LA, Bäumer T, Bosch A, van de Casteele M, Datema MR, Dekker H, Donnelly C, Driessens MHE, Graessner H, Greger V, Haddad T, Höglinger GU, van den Hout H, Jonker C, Langeveld M, Lambert LJ, Neacy E, Nieuwland M, Klockgether T, van der Knaap MS, Papadopoulou A, Plueschke K, van Rijn S, Rosenberg N, Saunier-Vivar EF, Dos Santos Vieira B, Hollak CEM, Goettsch WG, Wolf NI. Schoenmakers DH, et al. Among authors: goettsch wg. Neurology. 2024 Sep 24;103(6):e209743. doi: 10.1212/WNL.0000000000209743. Epub 2024 Aug 22. Neurology. 2024. PMID: 39173102 Free PMC article.
182 results